Inicio › Diabetes tipo 2 › Alabama › Birmingham
Ensayos clínicos de Diabetes tipo 2 en Birmingham, AL
16 estudios para Diabetes tipo 2 buscan participantes en centros de Birmingham y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
ReclutandoFase 3
- Cahaba Research, Inc. - Trussville Location, Birmingham
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
ReclutandoFase 3
- Birmingham Clinical Research, Birmingham
A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)
ReclutandoFase 3
- Central Alabama Research, Birmingham
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
ReclutandoFase 3
- Research Site, Birmingham
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
ReclutandoFase 2
- Central Research Associates, LLC dba Flourish Research, Birmingham
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
ReclutandoFase 2
- Flourish Research, Birmingham
Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT)
Reclutando
- UAB Highlands Hospital/Department of Family and Community Medicine, Birmingham
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
Reclutando
- University of Alabama, Birmingham
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
Reclutando
- University of Alabama, Birmingham
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
ReclutandoFase 3
- AURORA-2 Clinical Site, Birmingham
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
ReclutandoFase 3
- Univ of Alabama Birmingham, Birmingham
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
ReclutandoFase 3
- Research Site, Birmingham
CGM for Management of Type 2 Diabetes in Pregnancy
Reclutando
- University of Alabama at Birmingham, Birmingham
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
ReclutandoEstudio observacional
- University of Alabama at Birmingham, Birmingham
FELLAShip to Better Health
Reclutando
- The Worship Center Cristian Church, Birmingham
A Low-Carb Approach to Treat Type 2 Diabetes in Pediatric Patients
Reclutando
- University of Alabama at Birmingham/ Children's of Alabama, Birmingham
Más información sobre Diabetes tipo 2 en MedlinePlus
Ensayos de Diabetes tipo 2 en otras ciudades
- San Antonio, TX37 estudios
- Houston, TX31 estudios
- Orlando, FL25 estudios
- Atlanta, GA21 estudios
- San Diego, CA21 estudios
- Boston, MA20 estudios
- Miami, FL20 estudios
- Chicago, IL19 estudios
- Arlington, VA19 estudios
- Los Angeles, CA18 estudios
- Dallas, TX18 estudios
- Columbus, OH17 estudios
Otros estudios en Birmingham
- Cáncer (todos los tipos)30 estudios
- Cáncer de ovario25 estudios
- Cáncer de seno24 estudios
- Cáncer de pulmón de células no pequeñas23 estudios
- Obesidad22 estudios
- Leucemia mielógena aguda21 estudios
- Enfermedad de obstrucción pulmonar crónica17 estudios
- Mieloma múltiple17 estudios
- Enfermedad cardiovascular16 estudios
- Cáncer de endometrio16 estudios
- Sobrepeso16 estudios
- Fibrosis quística15 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.